Skip to content
10-Q

Quarterly Report

Pyxis Oncology, Inc. PYXS

0001193125-26-222843

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 8, 2026 63.36M sh
Shares Diluted Q1 2026 · Mar 31, 2026 63.47M sh
Shares Diluted Q1 2026 · Mar 31, 2025 61.05M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$26M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$22.54M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $5.77M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $15.42M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $12.76M
Stockholders Equity Q1 2026 · Mar 31, 2026 $31.27M
Stockholders Equity Q1 2026 · Dec 31, 2025 $53.41M
Stockholders Equity Q1 2026 · Mar 31, 2025 $103.1M
Stockholders Equity Q1 2026 · Dec 31, 2024 $120.75M
Current Liabilities Q1 2026 · Mar 31, 2026 $16.53M
Current Liabilities Q1 2026 · Dec 31, 2025 $21.13M
Total Liabilities Q1 2026 · Mar 31, 2026 $33.03M
Total Liabilities Q1 2026 · Dec 31, 2025 $38.11M
Current Assets Q1 2026 · Mar 31, 2026 $45.57M
Current Assets Q1 2026 · Dec 31, 2025 $72.11M
Total Assets Q1 2026 · Mar 31, 2026 $64.3M
Total Assets Q1 2026 · Dec 31, 2025 $91.52M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.37
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.35
Eps Basic Q1 2026 · Mar 31, 2026 −$0.37
Eps Basic Q1 2026 · Mar 31, 2025 −$0.35
Sga Expense Q1 2026 · Mar 31, 2026 $4.38M
Sga Expense Q1 2026 · Mar 31, 2025 $5.87M
Rd Expense Q1 2026 · Mar 31, 2026 $19.98M
Rd Expense Q1 2026 · Mar 31, 2025 $17.04M
Net Income Q1 2026 · Mar 31, 2026 −$23.27M
Net Income Q1 2026 · Mar 31, 2025 −$21.16M
Operating Income Q1 2026 · Mar 31, 2026 −$24.36M
Operating Income Q1 2026 · Mar 31, 2025 −$22.91M